Technology
e-Newsletter
Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

GE invests $5 million in heart disease test maker

AP/ABC News, May 14, 2010

General Electric Co.'s healthcare unit has announced a partnership with CardioDx, which develops genetic tests that are used in diagnosing heart disease. GE Healthcare, which makes diagnostic and medical imaging products, said it invested $5 million in CardioDx through an equity fund that invests in healthcare technology companies. CardioDx makes genetic tests that can be used in treatment of people with conditions including heart failure and coronary artery disease.